Skip to content

ROIVANT SCIENCES Price, Chart & Factor Exposure

Free Data & Analytics Access

Next earnings: Thu, Feb 4, 2027, before the market opens · estimates and history

ROIVANT SCIENCES · E.87S.F · Germany
Use symbol E.87S.F in our API & Excel add-in to retrieve this data ↓
34.79
(-0.01%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 50%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 54.39%

ROIVANT SCIENCES Forecast

ROIVANT SCIENCES short-term momentum is positive (up over 3 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 54.4% a year, a typical one-standard-deviation range is 32.13–37.46 over a week, 29.33–40.25 over a month and 15.87–53.72 over a year. (Signals as of 22 Nov 2026.)

ROIVANT SCIENCES Price Chart

MacroFinance.ai

ROIVANT SCIENCES Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
ROIVANT SCIENCES
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
ROIVANT SCIENCES
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
ROIVANT SCIENCES
Signal
0
ⓘLatest reading of Signal.
Teal = supportive for ROIVANT SCIENCES, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Research on ROIVANT SCIENCES

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

ROIVANT SCIENCES Trading Strategies

9 backtested tactical asset allocation strategies hold VGK (European market), the closest tradable exposure to ROIVANT SCIENCES; 1 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

Explore all strategies →

Statistical Distribution of Returns

Plus

How ROIVANT SCIENCES’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how ROIVANT SCIENCES behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About ROIVANT SCIENCES (Germany)

ROIVANT SCIENCES is a listed security in Germany. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is ROIVANT SCIENCES?
ROIVANT SCIENCES is a listed security in Germany. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest ROIVANT SCIENCES price?
The latest close is 34.79 (22 Nov 2026), -0.01% on the day. The price at the top of the page refreshes during the trading day.
Is ROIVANT SCIENCES in an uptrend?
As of 22 Nov 2026, short-term momentum is positive (3 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is ROIVANT SCIENCES?
20-day realised volatility is 54.4% a year (22 Nov 2026), which implies a typical one-standard-deviation move of about 15.7% over a month and 7.7% over a week.
What factors affect ROIVANT SCIENCES?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to ROIVANT SCIENCES, grouped as Quantitative Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade ROIVANT SCIENCES?
9 backtested tactical asset allocation strategies trade ROIVANT SCIENCES through VGK; 1 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are ROIVANT SCIENCES returns analysed?
The Statistical Distribution of Returns section shows the distribution of ROIVANT SCIENCES daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free ROIVANT SCIENCES historical data?
In the Free historical data section of this page: the last 10 years of ROIVANT SCIENCES daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free ROIVANT SCIENCES historical data (last 10 years)

Browse or instantly download the last 10 years of ROIVANT SCIENCES daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.87S.F&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-1834.792
2026-11-1734.999
2026-11-1635.381
2026-11-1335.549
2026-11-1237.009
2026-11-1136.769
2026-11-1035.706
2026-11-0934.514
2026-11-0631.875
2026-11-0533.688
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease; neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising a lipid nanoparticle (LNP) platform and a ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.